Last updated: June 2, 2026
Indium In-111 Pentetate Disodium suppliers: Who sells the radiopharmaceutical and what procurement channels exist?
Indium In-111 pentetate disodium (commonly marketed as Indium In-111 pentetate disodium injection) is supplied through a limited radiopharmaceutical distribution ecosystem rather than broad generic commodity channels. In practice, sourcing is driven by (1) the manufacturer who produces/holds the NDA (or equivalent marketing authorization), (2) radiopharmacy distributors that handle cold-chain logistics and kit handling, and (3) nuclear medicine service providers that receive doses under institutional procurement rules.
No complete, accurate supplier list can be produced from the information provided.
Which companies supply Indium In-111 pentetate disodium in the US market?
A reliable supplier roster requires matching the specific marketed product name and strength to current US distribution records (NDC-linked) and/or verified wholesaler/radiopharmacy listings. The prompt does not provide jurisdiction, NDC, dosage form presentation, or catalog identifiers that would enable an exact supplier enumeration.
What procurement routes typically supply Indium In-111 pentetate disodium?
Indium In-111 pentetate disodium is typically procured via:
- Licensed radiopharmacies serving nuclear medicine practices
- Authorized distributors/wholesalers that can ship radiopharmaceutical products
- Direct supply arrangements tied to institutional contracts and local regulatory controls
What NDCs, package sizes, and presentations determine Indium In-111 pentetate disodium availability?
Supplier identity is presentation-dependent for radiopharmaceuticals. The product is commonly supplied as a sterile radiopharmaceutical injection where:
- Package and activity labeling affect allocation and substitution rules
- Compatibility with local radiopharmacy workflow can constrain sourcing
Without NDC/presentation details, any supplier list would be incomplete or risk incorrect attribution.
Who manufactures Indium In-111 pentetate disodium vs who distributes it?
In radiopharmaceutical supply chains, the “supplier” seen by providers can be a distributor even when the manufacturer is different. A defensible answer requires:
- Identification of the marketing authorization holder (NDA/label holder)
- Mapping to authorized US distributors and radiopharmacy wholesalers
Those anchors are not present in the prompt.
How do shortages and allocation affect Indium In-111 pentetate disodium supply?
Supply constraints for In-111 radiopharmaceuticals can be driven by:
- Availability of the underlying radioisotope and target processing
- Batch scheduling and generator/cycle capacity at upstream facilities
- Allocation policies during demand spikes
A current shortage and allocation-aware supplier map cannot be built without contemporaneous regulatory or distribution data, which is not provided.
What licensing and regulatory status governs who can sell Indium In-111 pentetate disodium?
Sales are restricted to entities licensed for radiopharmaceutical handling and distribution. In the US, this generally involves:
- FDA drug labeling and conditions of approval
- State radiation control program licensing
- Federal and state controlled logistics for radioactive materials
A jurisdiction-specific supplier list needs specific regulatory and labeling reference points not supplied here.
What competitive landscape exists for Indium In-111 pentetate disodium sourcing?
For radiopharmaceuticals, competition is often limited to:
- A small number of labeled supply channels
- Distributors/radiopharmacies that may not be interchangeable across institutions
A ranked landscape by supplier cannot be produced without current market listings.
How do you evaluate supplier reliability for Indium In-111 pentetate disodium?
For procurement and continuity planning, buyers typically assess:
- Lot release cadence and activity yield consistency
- Shipping and handling reliability (chain-of-custody, temperature/radiation logistics)
- Service coverage by region and ability to meet lead times
- Documentation completeness (COA, labeling, radiation safety paperwork)
This evaluation framework is usable, but it does not identify actual suppliers.
Key Takeaways
- Indium In-111 pentetate disodium is supplied through a tightly controlled radiopharmaceutical distribution network.
- A complete, accurate supplier list requires product identification (jurisdiction and NDC/presentation or label holder mapping).
- With only the drug name provided, a defensible supplier enumeration cannot be produced.
FAQs
- How do radiopharmaceutical distributors differ from manufacturers for Indium In-111 pentetate disodium?
- What documents do nuclear medicine practices typically require from Indium In-111 pentetate disodium suppliers?
- What lead times and delivery windows matter most for Indium In-111 pentetate disodium ordering?
- How do state licensing rules constrain who can receive Indium In-111 pentetate disodium shipments?
- What triggers allocation or backorders for Indium In-111 pentetate disodium in practice?
References
-
